Search is Powered by Google
Breast Cancer News

German-Russian Collaboration In International Research

Main Category: Breast Cancer
Also Included In: Public Health;  Biology / Biochemistry;  Genetics
Article Date: 20 Sep 2007 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

An important part of the mission of the FAIR Russia Research Centre (FRRC), to be jointly financed by ROSATOM and the Helmholtz Association, will be to provide opportunities for young, high-calibre Russian scientists to be involved in the construction of FAIR. Doctoral and postdoctoral candidates from Russia will enjoy highly favourable working conditions at the FRRC in addition to involvement in international research. Promising young foreign scientists visiting the FRRC will benefit from the knowledge of outstanding Russian physicists while gaining exposure to Russia's dynamic research infrastructure. "This represents another milestone in German-Russian collaboration, which is something we value highly and have been expanding for many years," said Professor Jürgen Mlynek, President of the Helmholtz Association.

The involvement of the Helmholtz Association with Russian scientific research goes even further however. Together with the Russian Foundation for Basic Research, the first eight Helmholtz Russia Joint Research Groups were selected from a field of 25 applications. Each of these research groups, composed primarily of up-and-coming German and Russian research scientists, will be provided an annual budget of €150,000 for a period of three years. The funds will be used for joint experiments and expeditions as well as to create more attractive working conditions for next-generation Russian scientists in their home country in parallel to their inclusion in major international research projects conducted by the Helmholtz Association.

The following Helmholtz Russia Joint Research Groups were selected:

Title: Physics Analysis and Calorimetry at the Terascale
German Partner: Deutsches Elektronen-Synchtrotron
Russian Partner: Institute for Theoretical and Experimental Physics (ITEP)
German Co-leader: Dr. Kerstin Borras
Russian Co-leader: Dr. Roman Mizuk

Title: High Dose Irradiation Damage of RAFM Steels
German Partner: Forschungszentrum Karlsruhe
Russian Partner: Ulyanovsk State University
German Co-leader: Dr. Ermile Gaganidze
Russian Co-leader: Dr. Viacheslav V. Svetukhin

Title: Hydrogen Isotopes Retention in First-Wall Materials for ITER and Fusion Power Reactors
German Partner: Max-Planck-Institut für Plasmaphysik
Russian Partner: Moscow Engineering and Physics Institute (MEPhI)
German Co-leader: Dr. Matej Mayer
Russian Co-leader: Dr. Anna V. Golubeva

Title: Molecular pathogenesis of bilateral breast cancer
German Partner: German Cancer Research Centre
Russian Partner: N.N. Petrov Institute of Oncology
German Co-leader: Prof. Dr. Manfred Schwab
Russian Co-leader: Evgeny N. Suspitsin, MD., PhD

Title: Structural aspects of biocompatible ferrofluids by scattering methods: Stabilization, properties control and applications
German Partner: GKSS-Forschungszentrum Geesthacht
Russian Partner: Joint Institute for Nuclear Research (JINR)
German Co-leader: PD Dr. Regine Willumeit
Russian Co-leader: PD Dr. Mikhail Avdeev

Title: ECOLINK - Understanding effects of environmental toxicants at population and community levels: A link between ecotoxicological experiments and field observations within Eurasian climate scenarios UFZ
German Partner: Helmholtz Centre for Environmental Research - UFZ
Russian Partner: Institute of Systematics and Ecology of Animals, SB RAS
German Co-leader: PD Dr. Matthias Liess
Russian Co-leader: Dr. (C.Sc.)Yury Yurchenko

Title: Actinide nano-particles: formation, stability, and properties relevant to the safety of nuclear waste disposal
German Partner: Forschungszentrum Karlsruhe
Russian Partner: Chemistry Department of Lomonosov Moscow State University (MSU)
German Co-leader: Dr. Melissa A. Denecke
Russian Co-leader: Dr. Stepan N. Kalmykov

Title: Derivation of germ line competent rat ES cells for gene targeting
German Partner: Max Delbrück Centre for Molecular Medicine Berlin-Buch
Russian Partner: Institute of Cytology, Russian Academy of Sciences
German Co-leader: Dr. Natalia Alenina
Russian Co-leader: Alexey Tomilin, PhD

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The Helmholtz Association has been commissioned with performing research which contributes substantially to answering the grand challenges of science, society and industry through scientifically excellent efforts in six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Transport and Space. The Helmholtz Association is Germany's largest scientific research association. A total of 25,700 staff work in its 15 research centres. The association's annual budget runs to more than € 2 billion. Its research stands in the tradition of the universal scholar Hermann von Helmholtz (1821-1894). http://www.helmholtz.de/

Source: Thomas Gazlig
Helmholtz Association of German Research Centres


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...